— Know what they know.
Not Investment Advice

PCYN OTC

Procyon Corporation
1W: +3.9% 1M: +8.0% 3M: +34.3% YTD: +123.1% 1Y: +145.4% 3Y: +12.5% 5Y: -61.4%
$0.27
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 59 · $2.2M mcap · 3M float · 0.199% daily turnover · Short 90% of daily vol

Balance Sheet Trends

Total Assets
$3M +7.7% ▲
5Y CAGR: +4.1%
Total Liabilities
$1M +22.2% ▲
5Y CAGR: +11.2%
Shareholders Equity
$2M +1.8% ▲
5Y CAGR: +1.5%
Cash & Investments
$413K -54.5% ▼
5Y CAGR: -12.8%
Total Debt
$139K -56.5% ▼
5Y CAGR: -7.1%
Net Debt
$59K +1033.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$1M$760K$451K$326K$81K
Short-Term Investments$280K$281K$562K$583K$333K
Cash & ST Investments$2M$1M$1M$909K$413K
Net Receivables$497K$407K$494K$513K$632K
Inventory$591K$762K$431K$510K$696K
Other Current Assets$0$0$0$0$0
Total Current Assets$3M$3M$2M$2M$3M
Property, Plant & Equip.$992K$860K$808K$600K$380K
Goodwill & Intangibles$17K$17K$17K$17K$17K
Long-Term Investments$0$12K$0$0$0
Other Non-Current Assets$267K$182K$340K$221K$299K
Total Non-Current Assets$1M$1M$1M$839K$797K
Total Assets$4M$4M$4M$3M$3M
— Liabilities —
Accounts Payable$168K$178K$175K$161K$462K
Short-Term Debt$154K$163K$0$0$139K
Deferred Revenue$0-$163K$0$0$0
Other Current Liabilities-$55K$0$149K$183K$175K
Total Current Liabilities$736K$643K$626K$769K$1M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$654K$491K$320K$148K$79K
Total Liabilities$1M$1M$946K$917K$1M
— Equity —
Common Stock$4M$4M$4M$4M$4M
Retained Earnings-$2M-$2M-$2M-$2M-$2M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$3M$3M$3M$2M$2M
Total Liabilities & Equity$4M$4M$4M$3M$3M
— Key Metrics —
Total Debt$808K$857K$493K$320K$139K
Net Debt-$419K$96K$42K-$6K$59K
Total Investments$280K$293K$562K$583K$333K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms